RedCo II Master Fund, L.P.
- SEC CIK
- 0001921783
In the past year, 1 open-market sale filing worth $19.6M and no purchases.
Current role at each company
- FATE Fate Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- ADCT ADC Therapeutics SA10% Owneras of Apr 2, 2026
- AUGX Augmedix, Inc.Director, 10% Owneras of Oct 4, 2024
- MDVL MedAvail Holdings, Inc.Director, 10% Owneras of Jun 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $19.6M
- 1 filing
- Net
- −$19.6M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists RedCo II Master Fund, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADCT ADC Therapeutics SA
10% Owner15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 (view filing)9:50 PM ET | Jan 3-Feb 7 | 37 daysLate | Redmile Group, LLC and 2 others10% Owner | PPurchase | +1.79M | – | – | –107.6K after | Derivative18 lots |
| Feb 9, 2024 (view filing)9:50 PM ET | Feb 1-2 | 8 daysLate | Redmile Group, LLC and 2 others10% Owner | PPurchase | +27.0K | – | – | –11.2K after | Derivative2 lots |
| May 10, 2024 (view filing)4:01 PM ET | May 8 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchase | +6.11M | $4.81 | +$29.4M | –6.11M after | Derivative |
| May 10, 2024 (view filing)4:01 PM ET | May 8 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchase | +8.16M | $4.81 | +$39.3M | –8.16M after | Derivative |
| Jul 3, 2024 (view filing)8:00 PM ET | Jul 1 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +400.0K | $2.81 | +$1.12M | +2.6%15.7M after | |
| Jul 3, 2024 (view filing)8:00 PM ET | Jul 1 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +400.0K | $2.81 | +$1.12M | +3.2%13.0M after | |
| Dec 6, 2024 (view filing)9:00 PM ET | Dec 4 | 2 days | Redmile Group, LLC and 2 others10% Owner | SSaleCommon Shares, par value CHF 0.08 per share | −25.4K | $2.07 | −$52.5K | −0.2%15.6M after | |
| Dec 13, 2024 (view filing)9:00 PM ET | Dec 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +100.0K | $3.05 | +$304.5K | +0.6%15.7M after | 2 lots |
| Dec 13, 2024 (view filing)9:00 PM ET | Dec 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Shares, par value CHF 0.08 per share | +100.0K | $3.05 | +$304.5K | +0.8%13.1M after | 2 lots |
| Jun 13, 2025 (view filing)6:00 PM ET | Jun 11 | 2 days | Redmile Group, LLC and 2 others10% Owner | PPurchaseCommon Share | +15.7M | $3.43 | +$54.0M | –15.7M after | Derivative |
AUGX Augmedix, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 (view filing)4:15 PM ET | Nov 20 | 2 days | Redmile Group, LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $4.00 | +$3.00M | +4.8%16.4M after | |
| Nov 22, 2023 (view filing)4:15 PM ET | Nov 20 | 2 days | Redmile Group, LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $4.00 | +$3.00M | +8.6%9.45M after |